PerkinElmer Inc
NYSE:PKI
PerkinElmer Inc
Operating Income
PerkinElmer Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PerkinElmer Inc
NYSE:PKI
|
Operating Income
$783.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$661.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is PerkinElmer Inc's Operating Income?
Operating Income
783.1m
USD
Based on the financial report for Jan 1, 2023, PerkinElmer Inc's Operating Income amounts to 783.1m USD.
What is PerkinElmer Inc's Operating Income growth rate?
Operating Income CAGR 5Y
20%
Over the last year, the Operating Income growth was -42%. The average annual Operating Income growth rates for PerkinElmer Inc have been 25% over the past three years , 20% over the past five years .